| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.008 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |